Bg pattern

NASOLINA 0.57 mg/ml NASAL SPRAY SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use NASOLINA 0.57 mg/ml NASAL SPRAY SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Nasolina 0.57 mg/ml

Nasal Spray Solution

Oxymetazoline Hydrochloride

Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.

  • Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor, pharmacist, or nurse.
  • Keep this package leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor, pharmacist, or nurse, even if they are side effects not listed in this package leaflet. See section 4.
  • You should consult a doctor if your symptoms worsen or do not improve after 3 days.

Contents of the Package Leaflet:

  1. What Nasolina is and what it is used for
  2. What you need to know before taking Nasolina
  3. How to use Nasolina
  4. Possible side effects
  5. Storage of Nasolina
  6. Package Contents and Additional Information
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

1. What Nasolina is and what it is used for

It is a nasal decongestant medication that contains oxymetazoline as the active ingredient.

Oxymetazoline, when administered through the nose, produces a local constriction of blood vessels, which reduces nasal congestion.

It is indicated for the symptomatic relief of nasal congestion in adults, adolescents, and children from 6 years of age.

You should consult a doctor if your symptoms worsen or do not improve after 3 days of treatment.

2. What you need to know before taking Nasolina

Do not use Nasolina

  • if you are allergic to oxymetazoline, other nasal decongestants, or any of the other components of this medication (listed in section 6),
  • if you have ever suffered from insomnia or dizziness when treated with other sympathomimetic medications, such as those used to treat heart disease, hypotension (low blood pressure), or asthma,
  • if you are taking monoamine oxidase inhibitors (MAOIs, used to treat Parkinson's disease and depression). MAOIs may increase the hypertensive effects of oxymetazoline,
  • if you have narrow-angle glaucoma (increased eye pressure),
  • if you have recently undergone head surgery (if you have had any cranial, transnasal, or transoral surgical intervention),
  • if you have inflammation of the skin and mucosa of the nasal vestibule (anterior and lower part of the nasal cavities) and crusts in the nose (dry rhinitis),
  • if you suffer from acute heart disease or cardiac asthma,
  • if you suffer from severe hypertension,
  • in children under 6 years of age.

Warnings and Precautions

Consult your doctor, pharmacist, or nurse before using this medication if you have had or currently have any of the following diseases or symptoms:

  • high blood sugar levels (diabetes mellitus)
  • high blood pressure (arterial hypertension)
  • any heart or circulatory disease
  • increased eye pressure (glaucoma)
  • any prostate disease with difficulty urinating (prostatic hypertrophy)
  • any thyroid disease (hyperthyroidism)

In rare cases, oxymetazoline, due to its temporary effects and prolonged use, may increase nasal congestion instead of reducing it. This is known as rebound effect.

Rarely, insomnia may occur after using the medication. If this happens, avoid using it in the late afternoon or evening.

Do not exceed the recommended dose in section 3. How to use Nasolina

Using the same package by more than one person can lead to infections.

Children

Do not use in children under 6 years of age.

Children may be especially prone to adverse effects of this medication.

Other Medications and Nasolina

Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.

It is essential that you inform your doctor if you are taking or have taken in the last two weeks:

  • medications used to treat depression (monoamine oxidase inhibitor antidepressants, maprotiline, or tricyclic antidepressants)
  • a medication to lower blood pressure (methyldopa).

It should not be used in case of treatment with phenothiazine (tranquilizer) or medications to treat asthma.

This medication should not be used in conjunction with other vasoconstrictors.

Pregnancy and Breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Consult your doctor before using this medication to assess the benefits versus the potential risk.

Driving and Using Machines

The influence of this medication on the ability to drive and use machines is nil or insignificant.

Nasolina contains Benzyl Alcohol

This medication contains 1.04 mg of benzyl alcohol per spray. Benzyl alcohol may cause allergic reactions and moderate local irritation.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to use Nasolina

Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor, pharmacist, or nurse. In case of doubt, ask your doctor, pharmacist, or nurse.

The recommended dose is:

Adults, adolescents, and children over 6 years:

Apply one spray in each nostril, 2 times a day, as needed, once in the morning and once at night.

Do not exceed 2 applications in 24 hours.

Do not repeat applications at intervals of less than 12 hours.

Consult your doctor if symptoms worsen or do not improve after 3 days of treatment.

Do not exceed the recommended dose.

Use in children under 6 years

This medication cannot be used in children under 6 years of age (see section 2. Do not use Nasolina).

Elderly Patients (over 65 years)

Consult your doctor or pharmacist, as elderly patients are more sensitive to the adverse effects of this medication.

How to use Nasolina

This medication is used nasally.

Before application, blow your nose well to eliminate existing nasal fluids.

At the time of application, the product must be below 25°C to maintain it in solution form, which will gelify once applied to the nasal cavities.

Before the first use, the unit must be filled by pressing the pump several times until the first complete spray is produced.

To spray, hold the bottle between the palm and the index and thumb fingers.

Without tilting your head, insert the nozzle into the nostril. Press with a firm and uniform movement and perform one spray in each nostril. Keep the bottle in a vertical position.

Each person should use their own package to avoid infections.

To avoid contamination, clean the applicator tip with a clean, damp cloth, and close the package immediately after use.

You should consult a doctor if your symptoms worsen or do not improve after 3 days of treatment.

If you use more Nasolina than you should

In case of excessive dose application or very continuous use, or if you accidentally swallow the product, headaches, tremors, insomnia, excessive sweating, sleep disturbances, palpitations, tachycardia, and increased blood pressure may occur.

In children, these effects may include: convulsions and coma, hallucinations, decreased heart rate, temporary suspension of breathing, increased blood pressure that later becomes a decrease in blood pressure, excitability, urticaria, nausea, and vomiting, nervousness, somnolence or drowsiness, abnormal gait, facial edema.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service. Phone 91 5620420, indicating the medication and the amount ingested.

If you forget to use Nasolina

Do not use a double dose to make up for the forgotten dose.

If you have any other doubts about the use of this medication, ask your doctor or pharmacist.

4. Possible Side Effects

Like all medications, Nasolina can cause side effects, although not everyone will experience them.

The following side effects have been observed, whose frequency cannot be established with precision.

The most common side effects are: dryness in the nasal mucosa, sneezing, irritation of the nose, mouth, and throat, itching at the application site

Rare side effects that may occur are: allergic reaction, nervousness, agitation, anxiety, dizziness or drowsiness, sleep problems, somnolence, tremors, headache, hallucinations (particularly in children), blurred vision, tachycardia, palpitations, increased blood pressure, reactive hyperemia (blood accumulation in an organ due to vein obstruction), nasal burning, increased nasal secretion, dry mouth, nausea, rash, convulsions (particularly in children), and weakness.

Reporting Side Effects:

If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Nasolina

Keep this medication out of sight and reach of children.

No special storage conditions are required.

Do not use this medication after the expiration date indicated on the package after CAD. The expiration date is the last day of the month indicated.

Medications should not be disposed of through wastewater or household waste. Deposit the packages and medications you no longer need at the pharmacy's SIGRE point. In case of doubt, ask your pharmacist how to dispose of the packages and medications you no longer need. This way, you will help protect the environment.

6. Package Contents and Additional Information Composition of Nasolina

The active ingredient is oxymetazoline hydrochloride.

Each ml of nasal spray solution contains 0.57 mg of oxymetazoline hydrochloride (equivalent to 0.5 mg of oxymetazoline).

The other components (excipients) are 1.04 mg of benzyl alcohol, anhydrous glycerin, gelano CL-GA gum, eucalyptus essence, menthol, glycine, and purified water.

Appearance of the Product and Package Contents

Nasolina is a nasal spray solution that, due to the increase in temperature, in contact with the nasal mucosa, transforms into a gel.

Each bottle contains 20 ml of solution.

Marketing Authorization Holder and Manufacturer

Laboratorios Salvat, S.A.

C/. Gall 30-36, 08950 Esplugues de Llobregat, Barcelona,

Spain.

Date of the Last Revision of this Package Leaflet: May 2025

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for NASOLINA 0.57 mg/ml NASAL SPRAY SOLUTION

Discuss questions about NASOLINA 0.57 mg/ml NASAL SPRAY SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
5.0 (2)
Doctor

Alexander Nazarchuk

Allergology 7 years exp.

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

  • Test interpretation and guidance on diagnostic plans.
  • Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
  • Food and drug allergies, skin rashes, angioedema.
  • Atopic dermatitis, urticaria, contact allergies.
  • Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
  • Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
  • High blood pressure and adjustment of baseline antihypertensive therapy.
  • Hyperlipidaemia and elevated cholesterol.
  • Cough, nasal congestion, fever, sore throat.
  • Anaemia, including iron deficiency and related conditions.
  • Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.

Camera Book a video appointment
€55
0.0 (0)
Doctor

Marta Reguero Capilla

Allergology 8 years exp.

Dr Marta Reguero Capilla is an allergist and immunologist who works with both adults and children. She specialises in the diagnosis, treatment, and ongoing management of allergic and immune-related conditions through online consultations.

In her practice, Dr Reguero Capilla helps patients understand the causes of their symptoms, review test results, and choose appropriate treatment or monitoring strategies. Her consultations are suitable both for first-time assessments and for follow-up care over time.

Patients commonly consult Dr Marta Reguero Capilla for:

  • allergic rhinitis, seasonal allergies, and perennial allergy symptoms;
  • allergic conditions in adults and children;
  • bronchial asthma and allergy-related respiratory symptoms;
  • urticaria (acute and chronic) and angioedema;
  • food allergies and reactions to foods, additives, or medications;
  • atopic dermatitis, allergic rashes, and persistent itching;
  • unexplained or recurrent allergic reactions;
  • interpretation of laboratory tests, allergy testing, and immunology results;
  • immune system concerns, frequent infections, and reduced immune response;
  • ongoing medical follow-up and treatment adjustment.
Dr Reguero Capilla works in a structured and attentive manner, explaining medical decisions clearly and helping patients make informed choices about their own health or their child’s care.

When clinically appropriate, she may provide recommendations for further tests or referrals that patients can use within Spanish medical networks, including Sanitas and DKV, in accordance with the terms and conditions of those services.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for NASOLINA 0.57 mg/ml NASAL SPRAY SOLUTION?
NASOLINA 0.57 mg/ml NASAL SPRAY SOLUTION does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in NASOLINA 0.57 mg/ml NASAL SPRAY SOLUTION?
The active ingredient in NASOLINA 0.57 mg/ml NASAL SPRAY SOLUTION is oxymetazoline. This information helps identify medicines with the same composition but different brand names.
Who manufactures NASOLINA 0.57 mg/ml NASAL SPRAY SOLUTION?
NASOLINA 0.57 mg/ml NASAL SPRAY SOLUTION is manufactured by Laboratorios Salvat S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of NASOLINA 0.57 mg/ml NASAL SPRAY SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether NASOLINA 0.57 mg/ml NASAL SPRAY SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to NASOLINA 0.57 mg/ml NASAL SPRAY SOLUTION?
Other medicines with the same active substance (oxymetazoline) include CUVENAX 35 micrograms/PUFF NASAL SPRAY SOLUTION, INTERFRIN 0.5 mg/ml NASAL SPRAY SOLUTION, NASALVICKS 0.5mg/ml NASAL SPRAY SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media